In a new report from London's School of Pharmacy, Professor David Taylor (a contributor to the new CMPI/CNE book “Coincidence or Crisisâ€) points out: "The present system encourages traders to buy modern medicines cheaply in parts of Europe where governments impose low prices, and sell them on in new packages in EU member states where government controlled prices are higher. People think this saves money. But the evidence explored in our report indicates that it is in fact undermining European economic interests and may, on occasions, have created a pharmacy culture that increases counterfeit medicine hazards."
The report calls for stronger legal penalties for medicine counterfeiting and say they also support reform in other areas, from greater freedom of regulated medicines information provision in Europe to better controls over internet pharmacy and medicines trading. Importantly, the School of Pharmacy backs a strong patent system to fund medicines research and says without assets such as the research-based pharmaceutical industry "Europe's economic future will be bleak."
If you would like a copy of "Coincidence or Crisis," please send an email to ppitts@cmpi.org.
The report calls for stronger legal penalties for medicine counterfeiting and say they also support reform in other areas, from greater freedom of regulated medicines information provision in Europe to better controls over internet pharmacy and medicines trading. Importantly, the School of Pharmacy backs a strong patent system to fund medicines research and says without assets such as the research-based pharmaceutical industry "Europe's economic future will be bleak."
If you would like a copy of "Coincidence or Crisis," please send an email to ppitts@cmpi.org.
